Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thioctic Acid and Deprenyl in HIV Dementia
NCT00002154Phase 2Completed
- Sponsor
- Dana Foundation
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid, selegiline in HIV-associated dementia (HAD), sponsored by Dana Foundation. Status: completed.
02
Drugs
alpha-lipoic acidselegiline
03
Conditions
HIV-associated dementia (HAD)
Beyond the preview
Go deeper on NCT00002154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002154.